Cited by 104Probiotics and Fermented FoodsHIV Research and TreatmentGut microbiota and health

Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients

Open access
d'Ettorre, Gabriella, Rossi, Giacomo, Scagnolari, Carolina, Andreotti, Mauro, Giustini, Noemi, Serafino, Sara, Schietroma, Ivan, Scheri, Giuseppe Corano +11 more·2017·Immunity, Inflammation and Disease

Abstract

INTRODUCTION: HIV infection is characterized by a persistent immune activation associated to a compromised gut barrier immunity and alterations in the profile of the fecal flora linked with the progression of inflammatory symptoms. The effects of high concentration multistrain probiotic (Vivomixx®, Viale del Policlinico 155, Rome, Italy in EU; Visbiome®, Dupont, Madison, Wisconsin in USA) on several aspects of intestinal immunity in ART-experienced HIV-1 patients was evaluated. METHODS: A sub-study of a longitudinal pilot study was performed in HIV-1 patients who received the probiotic supplement twice a day for 6 months (T6). T-cell activation and CD4+ and CD8+ T-cell subsets expressing IFNγ (Th1, Tc1) or IL-17A (Th17, Tc17) were stained by cytoflorimetric analysis. Histological and immunohistochemical analyses were performed on intestinal biopsies while enterocytes apoptosis index was determined by TUNEL assay. RESULTS: , or both, and an increase in the percentage of Th17 cell subsets, especially those with central or effector memory phenotype, was recorded in the peripheral blood and in gut-associated lymphoid tissue (GALT) after probiotic intervention. Conversely, Tc1 and Tc17 levels remained substantially unchanged at T6, while Th1 cell subsets increase in the GALT. Probiotic supplementation was also associated to a recovery of the integrity of the gut epithelial barrier, a reduction of both intraepithelial lymphocytes density and enterocyte apoptosis and, an improvement of mitochondrial morphology sustained in part by a modulation of heat shock protein 60. CONCLUSIONS: These findings highlight the potential beneficial effects of probiotic supplementation for the reconstitution of physical and immunological integrity of the mucosal intestinal barrier in ART-treated HIV-1-positive patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/iid3.160

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Probiotics may contribute to the development of a nonspecific immune response in humans.

    “In addition to increasing the risk of infection, probiotics may contribute to the development of a nonspecific immune response in humans [83,84].”

    From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [83]

    The Discussion (page unavailable) reports that probiotic supplementation changed immune-cell patterns in ART-treated people with HIV-1, including increased Th17 frequencies. It does not establish that probiotics develop a nonspecific immune response in humans generally; the authors caution against generalizing their pilot findings to other probiotic formulations. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
d'Ettorre, G., Rossi, G., Scagnolari, C., Andreotti, M., Giustini, N., Serafino, S., Schietroma, I., Scheri, G. C., Fard, S. N., Trinchieri, V., Mastromarino, P., Selvaggi, C., Scarpona, S., Fanello, G., Fiocca, F., Ceccarelli, G., Antonelli, G., Brenchley, J. M., & Vullo, V.
Affiliations
  • Department of Public Health and Infectious Diseases Azienda Policlinico Umberto I of Rome Rome Italy
  • Università di Camerino (IT)
  • Istituto Pasteur (IT)
  • Istituto Superiore di Sanità (IT)
  • Sapienza University of Rome (IT)
  • Policlinico Umberto I (IT)
  • National Institutes of Health (US)
Venue
Immunity, Inflammation and Disease
Publisher
Wiley
Published
2017-04-20
Volume
5
Issue
3
Pages
244-260
ISSN
2050-4527 (ISSN-L)
OpenAlex
W2607084817
Cited by
104
References
63
Citations by year
2026: 3 · 2025: 2 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 20 · 2020: 18 · 2019: 14 · 2018: 14 · 2017: 8 · 2015: 1
FWCI
16.62
Type
journal article
Language
en
Open access
Locations
  • Immunity Inflammation and Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • Unicam Scientific Publications (University of Camerino) (submittedVersion, other-oa)
Funders
Institute Pasteur Italia, Cenci Bolognetti Foundation (55/2013)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, HIV-1, antiretroviral therapy, T cell activation, Th17 cells, Th1 cells, intestinal epithelial barrier, enterocyte apoptosis, mitochondrial morphology, heat shock protein 60, gut-associated lymphoid tissue, immune activation, gut microbiota
MeSH terms
Adult, HIV Seropositivity, Humans, Intestinal Mucosa, Lymphocyte Activation, Male, Middle Aged, Mitochondria, HIV-1, CD8-Positive T-Lymphocytes, Th1 Cells, Probiotics, Anti-Retroviral Agents, Th17 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review